Cargando…
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
BACKGROUND: The von Hippel–Lindau tumour suppressor protein–hypoxia-inducible factor (VHL–HIF) pathway has attracted widespread medical interest as a transcriptional system controlling cellular responses to hypoxia, yet insights into its role in systemic human physiology remain limited. Chuvash poly...
Autores principales: | Smith, Thomas G, Brooks, Jerome T, Balanos, George M, Lappin, Terence R, Layton, D. Mark, Leedham, Dawn L, Liu, Chun, Maxwell, Patrick H, McMullin, Mary F, McNamara, Christopher J, Percy, Melanie J, Pugh, Christopher W, Ratcliffe, Peter J, Talbot, Nick P, Treacy, Marilyn, Robbins, Peter A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479389/ https://www.ncbi.nlm.nih.gov/pubmed/16768548 http://dx.doi.org/10.1371/journal.pmed.0030290 |
Ejemplares similares
-
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2α gain-of-function mutation
por: Formenti, Federico, et al.
Publicado: (2011) -
Genetic Analysis of Pathways Regulated by the von Hippel-Lindau Tumor Suppressor in Caenorhabditis elegans
por: Bishop, Tammie, et al.
Publicado: (2004) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005) -
Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020) -
Hemangioblastomatosis in a patient with von Hippel-Lindau disease
por: Hanse, M. C. J., et al.
Publicado: (2007)